These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31579913)

  • 1. Genetic variants in m6A modification genes are associated with colorectal cancer risk.
    Meng Y; Li S; Gu D; Xu K; Du M; Zhu L; Chu H; Zhang Z; Wu Y; Fu Z; Wang M
    Carcinogenesis; 2020 Mar; 41(1):8-17. PubMed ID: 31579913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of lncRNAs N
    Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
    Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer.
    Song P; Feng L; Li J; Dai D; Zhu L; Wang C; Li J; Li L; Zhou Q; Shi R; Wang X; Jin H
    Mol Cancer; 2020 Aug; 19(1):129. PubMed ID: 32838807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
    Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
    RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANKLE1 N
    Tian J; Ying P; Ke J; Zhu Y; Yang Y; Gong Y; Zou D; Peng X; Yang N; Wang X; Mei S; Zhang Y; Wang C; Zhong R; Chang J; Miao X
    Int J Cancer; 2020 Jun; 146(12):3281-3293. PubMed ID: 31509622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
    Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
    Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress of N6-methyladenosine in colorectal cancer: A review.
    Lin Y; Shi H; Wu L; Ge L; Ma Z
    Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene signature and prognostic merit of M6a regulators in colorectal cancer.
    Zhang J; Cheng X; Wang J; Huang Y; Yuan J; Guo D
    Exp Biol Med (Maywood); 2020 Sep; 245(15):1344-1354. PubMed ID: 32605475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of N6-methyladenosine modification genes in Parkinson's disease.
    Qin L; Min S; Shu L; Pan H; Zhong J; Guo J; Sun Q; Yan X; Chen C; Tang B; Xu Q
    Neurobiol Aging; 2020 Sep; 93():143.e9-143.e13. PubMed ID: 32371107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of common genetic variants in vitamin E-related pathway genes and colorectal cancer susceptibility.
    Zhang Q; Meng Y; Du M; Li S; Xin J; Ben S; Zhang Z; Gu D; Wang M
    Arch Toxicol; 2021 Jul; 95(7):2523-2532. PubMed ID: 34009442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
    Chen M; Wong CM
    Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
    Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
    Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer.
    Qiao H; Liu L; Chen J; Shang B; Wang L
    Med Oncol; 2022 Sep; 39(12):235. PubMed ID: 36175777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.